These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 452141)

  • 21. [Comparative serum pharmacokinetics of prednisone and prednisolone methylsulfobenzoate after oral administration].
    Brion N; Pibarot ML; Atienza P; Robin P; Carbon C
    Presse Med; 1988 Apr; 17(12):569-71. PubMed ID: 2967477
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Removal of prednisone and prednisolone during plasma exchange].
    Assogba U; Baumelou A; Pecquinot MA; Raymond F; Durande JP; Lenoir G; Rottembourg J
    Ann Med Interne (Paris); 1988; 139 Suppl 1():38-9. PubMed ID: 3247989
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The transplacental passage of prednisone and prednisolone in pregnancy near term.
    Beitins IZ; Bayard F; Ances IG; Kowarski A; Migeon CJ
    J Pediatr; 1972 Nov; 81(5):936-45. PubMed ID: 5086721
    [No Abstract]   [Full Text] [Related]  

  • 24. Pharmacokinetics of prednisone and prednisolone in bullous pemphigoid patients.
    Chosidow O; Etienne SD; Diquet B; Vandermeersch V; Vu-Thi-My-Le C; Herson S; Puech AJ
    Int J Clin Pharmacol Ther Toxicol; 1991 Sep; 29(9):376-80. PubMed ID: 1938000
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Conversion of cortisone to cortisol and prednisone to prednisolone.
    Jenkins JS; Sampson PA
    Br Med J; 1967 Apr; 2(5546):205-7. PubMed ID: 6023103
    [No Abstract]   [Full Text] [Related]  

  • 26. [Prednisolone therapy of patients with chronic hepatitis and cirrhosis of the liver].
    Vasil'eva LN
    Klin Med (Mosk); 1966 May; 44(5):42-8. PubMed ID: 5990929
    [No Abstract]   [Full Text] [Related]  

  • 27. Effect of selection in controlled clinical trials. A supplement to the CSL prednisone trial in cirrhosis.
    Juhl E; Hilden M; Tygstrup N
    Scand J Gastroenterol Suppl; 1971; 9():171-5. PubMed ID: 5284140
    [No Abstract]   [Full Text] [Related]  

  • 28. Simple methods for estimation of prednisone intake and metabolism.
    Maayan R; Segal R; Feuerman EJ; Sandbank M; Kaufman H
    Biomed Pharmacother; 1988; 42(6):409-14. PubMed ID: 3219409
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bioavailability and reversible metabolism of prednisone and prednisolone in man.
    Garg V; Jusko WJ
    Biopharm Drug Dispos; 1994 Mar; 15(2):163-72. PubMed ID: 8011967
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Corticosteroids and the liver].
    Genes SG
    Klin Med (Mosk); 1977; 55(1):9-15. PubMed ID: 557148
    [No Abstract]   [Full Text] [Related]  

  • 31. Alternate-day prednisone in the maintenance immunosuppressive therapy after orthotopic liver transplantation.
    Pedrosa MC; Rohrer RM; Kaplan MM
    Clin Transplant; 1995 Aug; 9(4):322-5. PubMed ID: 7579741
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Long term therapy of chronic progressive (aggressive) hepatitis using a combination of imuran and prednisone].
    Schimmelpfennig W; Wagner K; Theuer D; Schneider G; Hecht A; Schimmelpfennig R
    Dtsch Gesundheitsw; 1971 Oct; 26(42):1965-71. PubMed ID: 5004132
    [No Abstract]   [Full Text] [Related]  

  • 33. Prednisolone clearance: a possible determinant for glucocorticoid efficacy in patients with oral vesiculo-erosive diseases.
    Lozada F; Frey FJ; Benet LZ
    J Dent Res; 1983 May; 62(5):575-7. PubMed ID: 6573375
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical pharmacokinetics of prednisone and prednisolone.
    Pickup ME
    Clin Pharmacokinet; 1979; 4(2):111-28. PubMed ID: 378499
    [No Abstract]   [Full Text] [Related]  

  • 35. [Prognosis of active liver cirrhosis with special regard to treatment with glucocorticoids].
    Mühler E; Zwirner K; Grow H
    Med Klin; 1967 Dec; 62(48):1869-73. PubMed ID: 5591973
    [No Abstract]   [Full Text] [Related]  

  • 36. [Systemic availability of prednisolone following oral administration of prednisone].
    Frey BM; Brandenberger AW; Frey FJ; Widmer HR
    Pharm Acta Helv; 1984; 59(11):301-9. PubMed ID: 6514760
    [No Abstract]   [Full Text] [Related]  

  • 37. [Hepatic biotransformation and conjugation of dehydrocholic acid in patients with cirrhosis (author's transl)].
    Poupon RY; Raizman A; Brumault JC; Infante R; Darnis F
    Gastroenterol Clin Biol; 1979 Dec; 3(12):879-84. PubMed ID: 535692
    [No Abstract]   [Full Text] [Related]  

  • 38. High doses of spironolactone in the treatment of liver cirrhosis with ascites.
    Papadoyanakis N; Darsinos J; Alexandrou K; Karli J
    Br J Clin Pract; 1972 Jan; 26(1):27-32. PubMed ID: 5025912
    [No Abstract]   [Full Text] [Related]  

  • 39. [Dosages in oral and parenteral steroid therapy].
    Kaiser H
    Dtsch Med Wochenschr; 1973 Mar; 98(10):518. PubMed ID: 4691578
    [No Abstract]   [Full Text] [Related]  

  • 40. Pharmacokinetics of 3 prednisolone prodrugs. Evidence of therapeutic inequivalence in renal transplant patients with rejection.
    Frey BM; Seeberger M; Frey FJ
    Transplantation; 1985 Mar; 39(3):270-4. PubMed ID: 3883592
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.